Managing Relationships With Industry

Paperback (Print)
Buy New
Buy New from BN.com
$42.99
Used and New from Other Sellers
Used and New from Other Sellers
from $22.22
Usually ships in 1-2 business days
(Save 55%)
Other sellers (Paperback)
  • All (7) from $22.22   
  • New (4) from $37.74   
  • Used (3) from $22.22   

Overview

Managing Relationships with Industry: A Physician’s Compliance Manual is an indispensable resource for doctors, professional societies, academic medical centers, community hospitals, and group practices struggling to understand the ever changing law and ethical standards on interactions with pharmaceutical and device companies. Authored by a former state Attorney General, Harvard Medical School Professor, health care lawyer and professor of ethics, it is the first comprehensive summary of the law and ethics on physician relationships with industry written for the physician.

Here is what some physician leaders are saying about Managing Relationships:

"This book is an important contribution to the ongoing discussion inside and outside the medical profession on the legal and ethical boundaries for doctors in their relationships with pharmaceutical and device makers."
-Donald M. Berwick, MD, MPP, President and CEO, Institute for Healthcare Improvement

“In these times, virtually all physicians have interactions with the industry, and this book addresses the relevant issues. Every practicing physician who makes contact with the health care industry will find this volume an invaluable reference – and a wonderful guide to both ethical and legal behavior.”
-Roger J. Porter, MD, Former Deputy Director of NINDS(NIH); Co-Author of Biomedical Research Collaboration and Conflict of Interest

“This book provides physicians, lawyers, and the public with an invaluable review of the ethical and legal issues raised by physician-industry relationships, and a practical guide to ethically-sound guidelines and policies”
-Lachlan Forrow, MD., Associate Professor of Medicine, Harvard Medical School, President, The Albert Schweitzer Fellowship

“The track record for the relief of human suffering by the pharmaceutical and device industry has been spectacular. For this progress to continue, all parties must work together, conscious of, adhering to, and always answerable to the question of conflict of self-interest. This book details solid legal and ethical guidance, which if followed, will move us in the right direction and create welcomed positive synergy between the pharmaceutical - medical device industry and physicians.”
-Leonard Morse, MD, Commissioner of Public Health, City of Worcester, Massachusetts; Professor of Clinical Medicine, Family Medicine and Community Health, University of Massachusetts Medical School; Past Chair of the AMA's Council on Ethical and Judicial Affairs.

Read More Show Less

Editorial Reviews

From the Publisher
“A timely balanced and thoughtful book combining important reference material, practical real world issues and broadly informed perspective that allow healthy dialogue among physicians, government, the public and the device and drug industries. An important step toward clearing the air and setting a course for de-risking physician-industry interactions and aligning incentives for improving patient care. Physicians and the public are exposed to polarized, incomplete and biased debates about how physicians and their organizations should manage their relationships with industry. This book gives one the wisdom and confidence to find the best balance between avoidance of conflicts and achieving the highest benefits for patients.”
-John A. Parrish, M.D., Executive Director and Founder of CIMIT, the Center for Integration of Medicine and Innovative Technology

“This book is an important contribution to the ongoing discussion inside and outside the medical profession on the legal and ethical boundaries for doctors in their relationships with pharmaceutical and device makers.”
-Donald M. Berwick, MD, MPP, President and CEO, Institute for Healthcare Improvement

“In these times, virtually all physicians have interactions with the industry, and this book addresses the relevant issues. Every practicing physician who makes contact with the health care industry will find this volume an invaluable reference – and a wonderful guide to both ethical and legal behavior.”
-Roger J. Porter, MD, Former Deputy Director of NINDS(NIH);Co-Author of Biomedical Research Collaboration and Conflict of Interest

“This book provides physicians, lawyers, and the public with an invaluable review of the ethical and legal issues raised by physician-industry relationships, and a practical guide to ethically-sound guidelines and policies”
-Lachlan Forrow, MD., Associate Professor of Medicine, Harvard Medical School, President, The Albert Schweitzer Fellowship

“The track record for the relief of human suffering by the pharmaceutical and device industry has been spectacular. For this progress to continue, all parties must work together, conscious of, adhering to, and always answerable to the question of conflict of self-interest. This book details solid legal and ethical guidance, which if followed, will move us in the right direction and create welcomed positive synergy between the pharmaceutical - medical device industry and physicians.”
-Leonard Morse, MD, Commissioner of Public Health, City of Worcester, Massachusetts; Professor of Clinical Medicine, Family Medicine and Community Health, University of Massachusetts Medical School; Past Chair of the AMA's Council on Ethical and Judicial Affairs.

Read More Show Less

Product Details

  • ISBN-13: 9780123736536
  • Publisher: Elsevier Science
  • Publication date: 6/3/2008
  • Pages: 324
  • Product dimensions: 5.90 (w) x 8.90 (h) x 0.90 (d)

Meet the Author

Table of Contents


Foreword     XIII
Preface     XXV
Contributors     XXXIII
Background     1
The Era of Big Business     4
Physicians and Industry Sales Representatives     7
Physicians Involved with Marketing to Other Physicians     15
Continuing Medical Education     16
Paying Doctors to Enroll Patients in Clinical Trials     17
Other Conflicts of Interest     18
Overview of Legal Sources     21
Anti-kickback Laws     23
Safe harbors     27
Interplay Between Anti-kickback and Stark Laws     39
Stark and Physician Self-Referral Laws     39
Drug and device companies are generally not Stark "entities"     40
Financial relationships under Stark     42
Sanctions     43
Indirect financial relationships and exceptions     44
Direct financial relationships     46
Federal False Claims Act     50
Whistleblower Qui Tam Actions     52
Use of the Federal False Claims Act (FCA) to Pursue Alleged Anti-kickback and Stark Violations     52
Civil Monetary Penalties     54
Exclusion from Medicare and Medicaid Programs     54
StateFalse Claims Acts and Whistleblower Laws     55
State Laws Regulating Marketing to Physicians     56
Food and Drug Administration     60
Off-label Uses and Marketing     62
Medicare Part D, Medicaid Drug Coverage and Other Program Changes to Prescription Drugs Coverage     67
Risks to Physicians     70
Summary of Recent Prosecutions and Investigations     73
Active Enforcement     73
The Prosecutable Case     76
Whistleblower as Private Attorney General     77
Settlements and Dispositions     78
Case Examples     79
Anti-kickback cases     79
Off-label marketing cases     84
Free sample/"marketing the spread" cases     94
Food, Drug, and Cosmetic Act False Statements Cases     100
Group purchasing organization cases     100
Physician Defendants in Cases Involving Financial Relationships with Industry     102
Applications of Law and Professional and Trade Association Standards to Physician Relationships with Industry     107
Office of Inspector General Reports     108
Office of Inspector General Special Fraud Alert     111
Office of Inspector General Compliance Program Guidance      112
Hospitals     113
Medical practices     115
Pharmaceutical manufacturers     116
Centers for Medicare and Medicaid Services Drug Manual     120
Corporate Integrity Agreements     122
Trade Association Codes of Conduct     122
PhRMA Code     123
AdvaMed Code     125
International Federation of Pharmaceutical Manufacturers and Associations Code of Pharmaceutical Marketing Practices     127
URAC Pharmacy Benefit Management Draft Standards     129
Medical Association and Society Codes of Conduct     130
American Medical Association Ethical Opinion 8.061 on Gifts to Physicians from Industry     130
The American Medical Association Position versus the No-Gift Movement     132
Other societies     134
Continuing Medical Education     139
Food and Drug Administration     140
Accreditation Council for Continuing Medical Education     141
Government interest     145
Medical education and communication companies     146
Clinical Practice Guidelines     147
Academic Medical Center Conflict-of-Interest Policies     147
Community Hospitals and Physician-Owned Medical Practices     151
Legal and Ethical Aspects of Specific Physician-Industry Financial Relationships     153
Gifts, Meals and Visits by Company Sales Representatives     158
The law on gifts to physicians     164
Manufacturer's support     167
Applicable state laws     168
The ethics of gifts to physicians     171
Detailing and Training     179
The law on detailing and training sessions     180
The ethics of detailing and training sessions     181
Continuing Medical Education     198
The law on continuing medical education     199
The ethics of continuing medical education     201
Non-CME Activities/Company Speakers Bureaus     205
The law on speaking for companies     205
The ethics of non-CME educational activities     206
Consulting and Other Service Arrangements     207
The law on consulting     208
The ethics of consulting     210
Preceptorships     211
Research Funding     212
The law on research funding from industry     213
The ethics of research funding from industry     214
Food and Drug Administration Advisory Committees     216
National Institutes of Health and Conflicts of Interest      217
AMA Ethical Standards for Researchers     219
Publishing Activities     221
Off-Label Marketing     222
The law on off-label marketing     223
The ethics of off-label marketing     225
Disclosure Considerations     227
Considerations for Medical Specialty Leaders     228
Equity Interests in Drug and Device Companies     228
Committee Memberships     229
Responding to a Subpoena or Interview Request by a Law Enforcement Official     230
Conclusion     232
Approaching and Adopting Effective Compliance Plans     233
Current Pressures on the U.S. Healthcare System     234
Physician shortages     234
Healthcare expenditures     235
The pipeline of medical innovations: diminishing returns     236
Addressing the Challenges: Key Stakeholders     237
Public and media     237
Physicians and their organizations     241
The Nature and Management of Conflict of Interest     244
Cognizance and understanding of the rules     247
Considerations for a Compliance Plan     249
The absolutist approach     249
Any degree of industry engagement      250
Developing Compliance Plans     254
Compliance plan elements     254
System-wide Reforms     256
Knowledge-based care: academic detailing and independent data sources     256
Stricter conflict-of-interest standards for health system stewards     258
Medical school curriculum on industry relationships     260
Professional society leadership     260
Broader compliance training for physicians on industry relationships     261
Patient education     261
Conclusion     263
Links to Frequently Cited Documents and Codes of Conduct     265
Key to Abbreviations     269
Model Service Agreement for Speaking at a Continuing Medical Education Activity     271
Model Agreement for Consulting     277
Index     283
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously
Sort by: Showing 1 Customer Reviews
  • Anonymous

    Posted May 30, 2008

    A reviewer

    A timely balanced and thoughtful book combining important reference material, practical real world issues and broadly informed perspective that allow healthy dialogue among physicians, government, the public and the device and drug industries. An important step toward clearing the air and setting a course for de-risking physician-industry interactions and aligning incentives for improving patient care. Physicians and the public are exposed to polarized, incomplete and biased debates about how physicians and their organizations should manage their relationships with industry. This book gives one the wisdom and confidence to find the best balance between avoidance of conflicts and achieving the highest benefits for patients.

    Was this review helpful? Yes  No   Report this review
Sort by: Showing 1 Customer Reviews

If you find inappropriate content, please report it to Barnes & Noble
Why is this product inappropriate?
Comments (optional)